Ambu - Public Comps and Valuation Multiples

Ambu Overview

About Ambu

Ambu AS provides medical technology solutions. The company’s business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.

Founded

1937

HQ

Employees

5.0K+

Website

ambu.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $949M

LTM EBITDA $168M

EV

$3.6B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Ambu Financials

As of October 2025, Ambu reported last 12-month revenue of $949M and EBITDA of $168M.

In the same period, Ambu generated $572M in LTM gross profit and $96.7M in net income.

See Ambu valuation multiples based on analyst estimates

Ambu P&L

In the most recent fiscal year, Ambu reported revenue of $935M and EBITDA of $179M.

Ambu expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Ambu valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$949M	XXX	$935M	XXX	XXX	XXX
Gross Profit	$572M	XXX	$562M	XXX	XXX	XXX
Gross Margin	60%	XXX	60%	XXX	XXX	XXX
EBITDA	$168M	XXX	$179M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	19%	XXX	XXX	XXX
EBIT	$124M	XXX	$121M	XXX	XXX	XXX
EBIT Margin	13%	XXX	13%	XXX	XXX	XXX
Net Profit	$96.7M	XXX	$94.3M	XXX	XXX	XXX
Net Margin	10%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Ambu including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $949M. EBITDA for the last twelve months was $168M. In the most recent fiscal year, Ambu achieved $935M in revenue and $179M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$949M	Analyst estimates available to subscribers	$935M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$572M	Analyst estimates available to subscribers	$562M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	60.3% gross margin	Analyst estimates available to subscribers	60.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$168M	Analyst estimates available to subscribers	$179M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	17.7% EBITDA margin	Analyst estimates available to subscribers	19.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$124M	Analyst estimates available to subscribers	$121M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	13.1% EBIT margin	Analyst estimates available to subscribers	13.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$96.7M	Analyst estimates available to subscribers	$94.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.2% net profit margin	Analyst estimates available to subscribers	10.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Ambu

This financial data table provides comprehensive performance metrics for Ambu, a company based in Denmark. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Ambu generated $949M in revenue over the last twelve months.
The company achieved $168M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $572M.
Net income over the last twelve months reached $96.7M.

Fiscal Year Performance

In the most recent fiscal year, Ambu reported $935M in total revenue.
Fiscal year EBITDA was $179M.
The company maintained a gross profit margin of 60.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 19.2%.
Net profit margin reached 10.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Ambu. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Ambu Stock Performance

Ambu has current market cap of DKK 23.4B (or $3.6B), and EV of DKK 23.1B (or $3.6B).

Market Cap Evolution

Ambu Stock Data

As of November 28, 2025, Ambu's stock price is DKK 88 (or $14).

See Ambu trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.6B	$3.6B	XXX	XXX	XXX	XXX	$0.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Ambu Valuation Multiples

Ambu's trades at 4.2x EV/Revenue multiple, and 28.9x EV/EBITDA.

See valuation multiples for Ambu and 15K+ public comps

Ambu Financial Valuation Multiples

As of November 28, 2025, Ambu has market cap of $3.6B and EV of $3.6B.

Equity research analysts estimate Ambu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ambu has a P/E ratio of 37.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$3.6B	XXX	$3.6B	XXX	XXX	XXX
EV (current)	$3.6B	XXX	$3.6B	XXX	XXX	XXX
EV/Revenue	3.8x	XXX	4.2x	XXX	XXX	XXX
EV/EBITDA	21.3x	XXX	28.9x	XXX	XXX	XXX
EV/EBIT	28.8x	XXX	34.0x	XXX	XXX	XXX
EV/Gross Profit	6.3x	XXX	n/a	XXX	XXX	XXX
P/E	37.6x	XXX	71.4x	XXX	XXX	XXX
EV/FCF	53.7x	XXX	46.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ambu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Ambu Margins & Growth Rates

Ambu's last 12 month revenue growth is 10%

Ambu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Ambu's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ambu's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Ambu and other 15K+ public comps

Ambu Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	11%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	14%	XXX	XXX	XXX
EBITDA Growth	18%	XXX	28%	XXX	XXX	XXX
Rule of 40	24%	XXX	24%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	43%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	30%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	47%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial